HolderBook

Rock Springs Capital Management LP

Reported holdings as of Q2 2026, from 31 quarterly filings.

CIK
1595725
Reported value
$2.0B
Positions
104
Top 10 weight
44.0%
Filed
2026-08-14
Days after quarter end
45

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
REVOLUTION MEDICINES INCRVMD$207.0M1,105,21010.10%+3.17pp14q-8.6%-$19.5M
TRAVERE THERAPEUTICS INCTVTX$123.8M2,179,0696.04%+3.45pp23q+47.4%+$39.8M
ELI LILLY & COLLY$118.4M98,7005.78%+0.43pp11qHELD
MADRIGAL PHARMACEUTICALS INCMDGL$94.0M174,9994.59%-0.69pp31q+2.3%+$2.1M
MIRUM PHARMACEUTICALS INCMIRM$93.4M798,1454.56%+0.14pp28q-1.6%-$1.5M
RHYTHM PHARMACEUTICALS INCRYTM$76.9M692,5983.75%+0.22pp31qHELD
KYMERA THERAPEUTICS INCKYMR$52.0M453,1562.54%+0.10pp24q-8.8%-$5.0M
ARGENX SEARGX$48.9M52,7502.39%-1.85pp31q-46.4%-$42.4M
ASCENDIS PHARMA A/SASND$45.0M168,7502.20%-newNEW
XENON PHARMACEUTICALS INCXENE$41.3M683,9072.01%-0.60pp26q-10.4%-$4.8M
SCHOLAR ROCK HLDG CORPSRRK$39.3M715,4521.92%-0.22pp7q-3.3%-$1.3M
INSMED INCINSM$38.6M362,1501.88%-1.14pp9q+15.2%+$5.1M
PENUMBRA INCPEN$36.5M115,7501.78%-0.55pp31q-3.9%-$1.5M
STRUCTURE THERAPEUTICS INCGPCR$34.4M640,3171.68%-0.14pp11qHELD
ULTRAGENYX PHARMACEUTICAL INRARE$32.3M967,8551.58%+0.07pp31q-20.6%-$8.4M
IRHYTHM HOLDINGS INCIRTC$32.1M269,6501.57%-0.26pp31q+3.0%+$939.7K
INTUITIVE SURGICAL INCISRG$30.4M76,4601.48%-0.74pp31q-6.8%-$2.2M
AGILON HEALTH INCAGL$28.1M262,6001.37%+1.25pp2q+1.0%+$278.7K
UNITEDHEALTH GROUP INCUNH$26.5M63,7501.29%+0.45pp3q+20.3%+$4.5M
CELLDEX THERAPEUTICS INC NEWCLDX$26.0M699,1461.27%+0.05pp18q+7.5%+$1.8M
ERASCA INCERAS$25.7M1,402,1501.25%+0.20pp3q+27.1%+$5.5M
NEUROCRINE BIOSCIENCES INCNBIX$24.4M144,7501.19%+0.02pp31q-3.8%-$960.6K
ENLIVEN THERAPEUTICS INCELVN$23.6M464,6251.15%-0.76pp10q-43.8%-$18.4M
TENET HEALTHCARE CORPTHC$23.4M125,0001.14%-0.25pp7qHELD
DEXCOM INCDXCM$23.1M343,0001.13%-0.19pp22q-3.5%-$848.6K
ACLARIS THERAPEUTICS INCACRS$22.9M4,330,5321.12%+0.13pp31q-3.2%-$751.8K
MINIMED GROUP INCMMED$22.7M1,520,0001.11%+0.18pp2q+44.1%+$7.0M
BOSTON SCIENTIFIC CORPBSX$22.6M528,5001.10%-0.80pp13q+2.6%+$563.4K
PHARVARIS N VPHVS$22.4M648,3331.09%+0.02pp10qHELD
AVALYN PHARMACEUTICALS INCAVLN$21.8M662,9181.07%-newNEW
HEMAB THERAPEUTICS HLDGS INC$21.1M575,4321.03%-newNEW
DYNE THERAPEUTICS INCDYN$20.9M942,1541.02%-0.02pp10q-3.1%-$667.3K
ALNYLAM PHARMACEUTICALS INCALNY$20.1M66,7500.98%-0.46pp31q-9.8%-$2.2M
COGENT BIOSCIENCES INCCOGT$20.0M515,9170.97%-0.44pp5q-17.3%-$4.2M
AGIOS PHARMACEUTICALS INCAGIO$19.8M532,5630.96%-0.63pp30q-33.4%-$9.9M
NEWAMSTERDAM PHARMA COMPANYNAMS$19.7M582,7440.96%-0.15pp8q-1.0%-$205.0K
VERA THERAPEUTICS INCVERA$18.3M427,5840.90%-0.30pp10q-15.1%-$3.3M
TARSUS PHARMACEUTICALS INCTARS$17.4M277,0870.85%-0.08pp7q+23.1%+$3.3M
HEARTFLOW INCHTFL$16.8M573,5000.82%flat4qHELD
MBX BIOSCIENCES INCMBX$16.5M298,2180.80%+0.30pp4q+3.6%+$565.9K
CYTOKINETICS INCCYTK$16.0M187,9800.78%+0.61pp3q+314.4%+$12.1M
BICARA THERAPEUTICS INCBCAX$15.9M535,2860.78%+0.20pp8q+9.4%+$1.4M
PARABILIS MEDICINES INCPBLS$15.8M578,0280.77%-newNEW
ZAI LAB LTDZLAB$15.5M814,7070.76%-0.15pp31qHELD
DANAHER CORP DELDHR$14.5M76,3000.71%+0.02pp6q+24.1%+$2.8M
TANGO THERAPEUTICS INCTNGX$14.3M456,5510.70%+0.22pp3q+18.0%+$2.2M
EVOLENT HEALTH INCEVH$13.6M2,500,0000.66%+0.30pp22q-6.5%-$948.5K
PTC THERAPEUTICS INCPTCT$13.2M162,2980.65%flat3qHELD
MINERALYS THERAPEUTICS INCMLYS$13.1M484,9510.64%-0.06pp6q+10.3%+$1.2M
ZENAS BIOPHARMA INCZBIO$12.7M502,0770.62%+0.04pp8qHELD
ARDELYX INCARDX$11.4M2,241,7690.56%-0.25pp7q-2.5%-$294.3K
INSPIRE MED SYS INCINSP$10.9M244,0000.53%+0.13pp12q+85.1%+$5.0M
BRIDGEBIO PHARMA INCBBIO$10.8M144,7500.53%-0.04pp4q+12.9%+$1.2M
ALKERMES PLCALKS$10.5M199,8110.51%+0.13pp4q+8.6%+$829.2K
SUMMIT THERAPEUTICS INCSMMT$10.4M715,0000.51%-0.28pp8q+0.7%+$72.8K
AZENTA INCAZTA$10.3M403,0000.50%-0.21pp17q-29.2%-$4.2M
INDIVIOR PHARMACEUTICALS INCINDV$10.1M245,5000.49%+0.13pp2q+22.8%+$1.9M
STRYKER CORPORATIONSYK$9.1M29,0000.45%+0.16pp2q+95.9%+$4.5M
AMYLYX PHARMACEUTICALS INCAMLX$9.0M499,7640.44%+0.03pp6qHELD
CARIS LIFE SCIENCES INCCAI$8.7M487,5000.42%-0.17pp5q-13.4%-$1.3M
OMADA HEALTH INCOMDA$8.2M373,0000.40%flat5q-31.1%-$3.7M
COMPASS THERAPEUTICS INCCMPX$7.7M3,524,9290.38%-0.65pp19q+6.6%+$481.0K
IMMUNOME INCIMNM$7.4M347,6660.36%-0.09pp3qHELD
EDAP TMS S AFOCL$7.2M1,386,0000.35%+0.05pp21q+0.6%+$41.4K
PHREESIA INCPHR$7.2M696,9000.35%+0.05pp28q+16.1%+$993.0K
OMEROS CORPOMER$6.8M718,4990.33%-newNEW
DEFINIUM THERAPEUTICS INCDFTX$6.7M143,1870.33%-newNEW
CORCEPT THERAPEUTICS INCCORT$6.3M72,0000.31%+0.19pp3q+43.3%+$1.9M
JANUX THERAPEUTICS INCJANX$5.6M367,0090.28%-0.03pp7qHELD
MOBIA MED INC$5.6M418,2000.27%-newNEW
ARCUS BIOSCIENCES INCRCUS$5.5M180,0000.27%+0.04pp3qHELD
THERMO FISHER SCIENTIFIC INCTMO$5.0M10,0000.24%-0.04pp5qHELD
TREVI THERAPEUTICS INCTRVI$4.8M260,0000.24%-newNEW
SIONNA THERAPEUTICS INCSION$4.4M99,4290.21%-0.02pp6qHELD
CVS HEALTH CORPCVS$4.1M40,0000.20%+0.03pp2qHELD
EYEPOINT INCEYPT$3.8M268,5190.19%-0.01pp4q+3.8%+$139.9K
OCULAR THERAPEUTIX INCOCUL$3.8M383,7160.18%-0.01pp4qHELD
SPYRE THERAPEUTICS INCSYRE$3.8M42,2540.18%-newNEW
TALPHERA INCTLPH$3.7M3,589,1860.18%+0.02pp15qHELD
ROIVANT SCIENCES LTDROIV$3.6M101,0000.17%+0.02pp3q+4.1%+$141.6K
VAXCYTE INCPCVX$3.5M60,2500.17%-0.04pp5qHELD
NEUROGENE INCNGNE$3.4M106,7500.16%+0.04pp7q+2.3%+$75.8K
CENTURY THERAPEUTICS INCIPSC$3.2M1,304,3470.16%-0.02pp2qHELD
ALPHATEC HLDGS INCATEC$3.1M360,0000.15%-0.07pp7q+2.9%+$86.5K
NOVO-NORDISK A SNVO$3.0M63,5000.15%-0.05pp2q-29.4%-$1.3M
OLEMA PHARMACEUTICALS INCOLMA$2.9M235,1780.14%-0.01pp3q+38.0%+$810.6K
NERVGEN PHARMA CORPNGEN$2.5M1,208,2310.12%-newNEW
MEDTRONIC PLCMDT$2.4M30,9000.12%-newNEW
TEVA PHARMACEUTICAL INDS LTDTEVA$2.0M59,0000.10%+0.02pp3q+29.7%+$457.4K
DIANTHUS THERAPEUTICS INCDNTH$2.0M20,3260.10%-0.04pp2q-24.0%-$626.9K
SAGIMET BIOSCIENCES INCSGMT$1.9M250,0000.09%-newNEW
CAPRICOR THERAPEUTICS INCCAPR$1.8M74,4480.09%-newNEW
LENZ THERAPEUTICS INCLENZ$1.5M257,4600.07%-0.07pp7qHELD
ALTIMMUNE INCALT$1.4M471,4650.07%-newNEW
KAILERA THERAPEUTICS INCKLRA$1.4M65,0000.07%-newNEW
SURGERY PARTNERS INCSGRY$1.4M84,0000.07%-0.08pp3q-59.6%-$2.1M
AXSOME THERAPEUTICS INCAXSM$1.3M5,5000.07%-newNEW
ORUKA THERAPEUTICS INCORKA$1.1M12,0510.06%+0.04pp2q+192.3%+$754.5K
VIKING THERAPEUTICS INCVKTX$994.8K25,5000.05%-0.14pp2q-73.4%-$2.8M
LEGEND BIOTECH CORPLEGN$967.5K33,5000.05%flat3q-17.3%-$202.2K
GLAUKOS CORPGKOS$663.9K4,7500.03%-newNEW
JASPER THERAPEUTICS INCJSPR$463.4K1,100,7260.02%-0.03pp10qHELD
BIOCRYST PHARMACEUTICALS INCBCRX$221.2K22,1240.01%flat2q+75.6%+$95.2K
MOONLAKE IMMUNOTHERAPEUTICSMLTX$208.3K10,6960.01%-0.06pp4q-82.7%-$993.0K

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 78.8%Medical Devices 10.6%Healthcare Services 3.6%Other sectors 3.8%Not classified 3.2%
 
SectorValueShare
Biotech & Pharma$1.6B78.8%
Medical Devices$217.6M10.6%
Healthcare Services$74.0M3.6%
Other sectors$77.0M3.8%
Not classified$65.8M3.2%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$2.0B1041735301344.0%45
Q1 2026$1.7B100113624940.6%45
Q4 2025$2.0B981831271239.8%48
Q3 2025$1.7B92922341037.7%45
Q2 2025$1.6B93928281236.1%45
Q1 2025$1.7B96624471736.6%45
Q4 2024$2.6B1071038291236.4%45
Q3 2024$3.1B10963229734.4%45
Q2 2024$3.3B110837271135.7%45
Q1 2024$3.9B113163811732.8%45
Q4 2023$4.1B104434292037.4%45
Q3 2023$3.7B120737221036.0%45
Q2 2023$4.2B12372816534.3%45
Q1 2023$4.2B1214418334.6%45
Q4 2022$4.2B12023723934.5%45
Q3 2022$3.9B12735011735.2%45
Q2 2022$3.4B131764121135.0%46
Q1 2022$4.0B1355709630.6%46
Q4 2021$4.3B136471152130.2%45
Q3 2021$4.8B1531164161426.3%46
Q2 2021$5.1B156146110927.4%47
Q1 2021$4.6B1511854272123.5%47
Q4 2020$4.7B1542239381624.4%47
Q3 2020$3.9B1482046301526.7%47
Q2 2020$3.6B143168110423.5%45
Q1 2020$2.4B1311641211525.9%45
Q4 2019$3.2B1301235312029.6%45
Q3 2019$2.5B13811469828.7%45
Q2 2019$2.8B13510419629.4%45
Q1 2019$2.6B13164314831.6%45
Q4 2018$2.1B133000032.6%45

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.